Generation and characterization of urokinase receptor-deficient mice

被引:189
作者
Dewerchin, M
VanNuffelen, A
Wallays, G
Bouche, A
Moons, L
Carmeliet, P
Mulligan, RC
Collen, D
机构
[1] MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142
[2] VLAAMS INTERUNIV INST BIOTEHNOL,CTR TRANSGENE TECHNOL & GENE THERAPY,B-3000 LOUVAIN,BELGIUM
[3] MIT,DEPT BIOL,CAMBRIDGE,MA 02142
关键词
gene targeting; embryonic stem cells; homologous recombination; extracellular proteolysis; fibrinolysis;
D O I
10.1172/JCI118489
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mice homozygously deficient for the urokinase-type plasminogen activator (u-PA) receptor (u-PAR(- -)) were generated by homologous recombination in D-3 embryonic stem cells. The genomic sequences comprising exon 2 through 5 of the u-PAR gene were replaced by the neomycin resistance gene, resulting in inactivation of both u-PAR splice variants. The inactivated u-PAR allele was transmitted via mendelian inheritance. and u-PAR(- -) mice displayed normal viability, grow th, and fertility. Inactivation of u-PAR was confirmed by the absence of binding of rabbit anti-murine u-PAR or of an aminoterminal fragment of murine u-PA (mu-PA.1-48) to u-PAR(- -) embryonic fibroblasts and macrophages. u-PAR(- -) mice displayed normal lysis of a murine plasma clot injected via the jugular vein. Invasion of macrophages into the peritoneal cavity after thioglycollate stimulation was similar in u-PAR(- -) and u-PAR(+/+) mice. u-PAR(- -) peritoneal macrophages had a threefold decreased initial rate of u-PA-mediated plasminogen activation in vitro but degraded extracellular matrix proteins in vitro as efficiently as u-PAR(- -) macrophages.
引用
收藏
页码:870 / 878
页数:9
相关论文
共 37 条
[1]   PRODUCTION OF 2ND MESSENGERS FOLLOWING CHEMOTACTIC AND MITOGENIC UROKINASE-RECEPTOR INTERACTION IN HUMAN FIBROBLASTS AND MOUSE FIBROBLASTS TRANSFECTED WITH HUMAN UROKINASE RECEPTOR [J].
ANICHINI, E ;
FIBBI, G ;
PUCCI, M ;
CALDINI, R ;
CHEVANNE, M ;
DELROSSO, M .
EXPERIMENTAL CELL RESEARCH, 1994, 213 (02) :438-448
[2]  
[Anonymous], 1989, MOL CLONING LAB MANU
[3]  
APPELLA E, 1987, J BIOL CHEM, V262, P4437
[4]  
BAKER MS, 1990, CANCER RES, V50, P4676
[5]  
BEHRENDT N, 1991, J BIOL CHEM, V266, P7842
[6]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[7]   THE UROKINASE RECEPTOR - STRUCTURE, REGULATION AND INHIBITOR-MEDIATED INTERNALIZATION [J].
BLASI, F ;
CONESE, M ;
MOLLER, LB ;
PEDERSEN, N ;
CAVALLARO, U ;
CUBELLIS, MV ;
FAZIOLI, F ;
HERNANDEZMARRERO, L ;
LIMONGI, P ;
MUNOZCANOVES, P ;
RESNATI, M ;
RIITTINEN, L ;
SIDENIUS, N ;
SORAVIA, E ;
SORIA, MR ;
STOPPELLI, MP ;
TALARICO, D ;
TEESALU, T ;
VALCAMONICA, S .
FIBRINOLYSIS, 1994, 8 :182-188
[8]  
Bradley A., 1987, TERATOCARCINOMAS EMB, P113
[9]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[10]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION [J].
CARMELIET, P ;
KIECKENS, L ;
SCHOONJANS, L ;
REAM, B ;
VANNUFFELEN, A ;
PRENDERGAST, G ;
COLE, M ;
BRONSON, R ;
COLLEN, D ;
MULLIGAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2746-2755